Mutations in sarcomere protein genes can cause hypertrophic cardiomyopathy (HCM), a disorder characterized by myocyte enlargement, fibrosis, and impaired ventricular relaxation. Here, we demonstrate that sarcomere protein gene mutations activate proliferative and profibrotic signals in non-myocyte cells to produce pathologic remodeling in HCM. Gene expression analyses of non-myocyte cells isolated from HCM mouse hearts showed increased levels of RNAs encoding cell-cycle proteins, Tgf-β, periostin, and other profibrotic proteins. Markedly increased BrdU labeling, Ki67 antigen expression, and periostin immunohistochemistry in the fibrotic regions of HCM hearts confirmed the transcriptional profiling data. Genetic ablation of periostin in HCM mice reduced but did not extinguish non-myocyte proliferation and fibrosis. In contrast, administration of Tgf-β–neutralizing antibodies abrogated non-myocyte proliferation and fibrosis. Chronic administration of the angiotensin II type 1 receptor antagonist losartan to mutation-positive, hypertrophy-negative (prehypertrophic) mice prevented the emergence of hypertrophy, non-myocyte proliferation, and fibrosis. Losartan treatment did not reverse pathologic remodeling of established HCM but did reduce non-myocyte proliferation. These data define non-myocyte activation of Tgf-β signaling as a pivotal mechanism for increased fibrosis in HCM and a potentially important factor contributing to diastolic dysfunction and heart failure. Preemptive pharmacologic inhibition of Tgf-β signals warrants study in human patients with sarcomere gene mutations.
Polakit Teekakirikul, Seda Eminaga, Okan Toka, Ronny Alcalai, Libin Wang, Hiroko Wakimoto, Matthew Nayor, Tetsuo Konno, Joshua M. Gorham, Cordula M. Wolf, Jae B. Kim, Joachim P. Schmitt, Jefferey D. Molkentin, Russell A. Norris, Andrew M. Tager, Stanley R. Hoffman, Roger R. Markwald, Christine E. Seidman, Jonathan G. Seidman
Title and authors | Publication | Year |
---|---|---|
Targeting E prostanoid receptor EP4 to treat cardiac fibrosis
Hu Xu, Xiuhui Mao, Yali Wang, Chunhua Zhu, Bo Liang, Yihang Zhao, Mengfei Zhou, Lan Ye, Mengting Hong, Huishu Shao, Yashuo Wang, Haonan Li, Yinghui Qi, Yongliang Yang, Youfei Guan, Xiaoyan Zhang |
Advanced science (Weinheim, Baden-Wurttemberg, Germany) | 2025 |
Contribution of hypoxia-inducible factor 1alpha to pathogenesis of sarcomeric hypertrophic cardiomyopathy
Raj Murthi S, Petry A, Shashikadze B, Stöckl JB, Schmid M, Santamaria G, Klingel K, Kračun D, Chen X, Bauer S, Schmitt JP, Flenkenthaler F, Gorham J, Toepfer CN, Potěšil D, Hruška P, Zdráhal Z, Mayer Z, Klop M, Lehmann L, Qin Y, Papanakli L, Spielmann N, Moretti A, Fröhlich T, Ewert P, Holdenrieder S, Seidman JG, Seidman CE, Görlach A, Wolf CM |
Scientific Reports | 2025 |
The Role of Signalling Pathways in Myocardial Fibrosis in Hypertrophic Cardiomyopathy
Skórka P, Piotrowski J, Bakinowska E, Kiełbowski K, Pawlik A |
Reviews in Cardiovascular Medicine | 2025 |
Valsartan and Cardiac Remodeling in Early-Stage Hypertrophic Cardiomyopathy: The VANISH Randomized Clinical Trial Cardiac Magnetic Resonance Substudy
Ostrominski JW, Claggett BL, Jerosch-Herold M, Raja AA, Day SM, Russell MW, Zahka K, Pereira AC, Colan SD, Murphy AM, Canter C, Bach RG, Wheeler MT, Rossano JW, Owens AT, Mestroni L, Taylor MR, Patel AR, Wilmot I, Soslow JH, Becker JR, Lakdawala NK, Bundgaard H, Vargas JD, Ho CY |
JAMA Cardiology | 2025 |
Cardiac Fibroblasts: Helping or Hurting
Shameem M, Olson SL, Marron Fernandez de Velasco E, Kumar A, Singh BN |
Genes | 2025 |
A case report of MYH7 mutation-induced restrictive cardiomyopathy
Zhang S, Zhao W |
European Heart Journal. Case Reports | 2025 |
The Role of Pro-Inflammatory Cytokines in the Pathogenesis of Cardiovascular Disease
Zhang H, Dhalla NS |
International journal of molecular sciences | 2024 |
Contemporary review on pediatric hypertrophic cardiomyopathy: insights into detection and management
Shafqat A, Shaik A, Koritala S, Mushtaq A, Sabbah BN, Nahid Elshaer A, Baqal O |
Frontiers in Cardiovascular Medicine | 2024 |
TGF-β signaling in health, disease, and therapeutics.
Deng Z, Fan T, Xiao C, Tian H, Zheng Y, Li C, He J |
Signal Transduction and Targeted Therapy | 2024 |
Empagliflozin and liraglutide ameliorate HFpEF in mice via augmenting the Erbb4 signaling pathway.
Ni XY, Feng XJ, Wang ZH, Zhang Y, Little PJ, Cao Y, Xu SW, Tang LQ, Weng JP |
Acta Pharmacologica Sinica | 2024 |
Substrate mechanics unveil early structural and functional pathology in iPSC micro-tissue models of hypertrophic cardiomyopathy
Guo J, Jiang H, Schuftan D, Moreno JD, Ramahdita G, Aryan L, Bhagavan D, Silva J, Huebsch N |
iScience | 2024 |
Single-nucleus RNA/ATAC-seq in early-stage HCM models predicts SWI/SNF-activation in mutant-myocytes, and allele-specific differences in fibroblasts
Thottakara T, Padmanabhan A, Tanriverdi T, Thambidurai T, Diaz-RG JA, Amonkar SR, Olgin JE, Long CS, Roselle Abraham M |
2024 | |
The Phenotypic Spectrum of Subclinical Sarcomere-related Hypertrophic Cardiomyopathy and Transition to Overt Disease
Topriceanu CC, Moon JC, Raja AA, Captur G, Ho CY |
Circulation. Genomic and precision medicine | 2024 |
Genetic testing and human leukocyte antigen in patients with hypertrophic cardiomyopathy and connective tissue diseases.
Hiraya D, Murakoshi N, Igarashi M, Xu D, Ishizu T |
Frontiers in genetics | 2024 |
Engineered model of heart tissue repair for exploring fibrotic processes and therapeutic interventions.
Yang P, Zhu L, Wang S, Gong J, Selvaraj JN, Ye L, Chen H, Zhang Y, Wang G, Song W, Li Z, Cai L, Zhang H, Zhang D |
Nature communications | 2024 |
A New Ex Vivo Model to Study Cardiac Fibrosis in Whole Mouse Hearts
Kruithof BP, Mousavi Gourabi B, van de Merbel AF, DeRuiter MC, Goumans MJ |
JACC: Basic to Translational Science | 2024 |
Hypertrophic cardiomyopathy-associated mutations drive stromal activation via EGFR-mediated paracrine signaling.
Ewoldt JK, Wang MC, McLellan MA, Cloonan PE, Chopra A, Gorham J, Li L, DeLaughter DM, Gao X, Lee JH, Willcox JAL, Layton O, Luu RJ, Toepfer CN, Eyckmans J, Seidman CE, Seidman JG, Chen CS |
Science advances | 2024 |
The clinical efficacy of cGMP-specific sildenafil on mitochondrial biogenesis induction and renal damage in cats with acute on chronic kidney disease.
Maden M, Ider M, Or ME, Dokuzeylül B, Gülersoy E, Kılıçkaya MC, Bilgiç B, Durgut MK, İzmirli S, Iyigün SS, Telci DZ, Naseri A |
BMC veterinary research | 2024 |
Integrative analysis of transcriptome, DNA methylome, and chromatin accessibility reveals candidate therapeutic targets in hypertrophic cardiomyopathy.
Gao J, Liu M, Lu M, Zheng Y, Wang Y, Yang J, Xue X, Liu Y, Tang F, Wang S, Song L, Wen L, Wang J |
Protein & cell | 2024 |
The Macrophage–Fibroblast Dipole in the Context of Cardiac Repair and Fibrosis
Psarras S |
Biomolecules | 2024 |
Obstructive hypertrophic cardiomyopathy: from genetic insights to a multimodal therapeutic approach with mavacamten, aficamten, and beyond
Sarwer K, Lashari S, Rafaqat N, Maher, Raheem A, Rehman MU, Abbas SM |
The Egyptian Heart Journal | 2024 |
Comprehensive Proteomic Profiling of Human Myocardium Reveals Signaling Pathways Dysregulated in Hypertrophic Cardiomyopathy
Lumish HS, Sherrid MV, Janssen PM, Ferrari G, Hasegawa K, Castillero E, Adlestein E, Swistel DG, Topkara VK, Maurer MS, Reilly MP, Shimada YJ |
Journal of the American College of Cardiology | 2024 |
PANoptosis is a prominent feature of desmoplakin cardiomyopathy
Olcum M, Rouhi L, Fan S, Gonzales MM, Jeong HH, Zhao Z, Gurha P, Marian AJ |
2023 | |
Efficient in vivo genome editing prevents hypertrophic cardiomyopathy in mice
Reichart D, Newby GA, Wakimoto H, Lun M, Gorham JM, Curran JJ, Raguram A, DeLaughter DM, Conner DA, Marsiglia JD, Kohli S, Chmatal L, Page DC, Zabaleta N, Vandenberghe L, Liu DR, Seidman JG, Seidman C |
Nature Medicine | 2023 |
Cardiac Resynchronization Therapy and Hypertrophic Cardiomyopathy: A Comprehensive Review
Radu AD, Cojocaru C, Onciul S, Scarlatescu A, Zlibut A, Nastasa A, Dorobantu M |
Biomedicines | 2023 |
Base editing correction of hypertrophic cardiomyopathy in human cardiomyocytes and humanized mice.
Chai AC, Cui M, Chemello F, Li H, Chen K, Tan W, Atmanli A, McAnally JR, Zhang Y, Xu L, Liu N, Bassel-Duby R, Olson EN |
Nature Medicine | 2023 |
Narrative review of pediatric heart failure in the age of precision medicine
Valikodath N, Godown J, Sheybani A |
Translational Pediatrics | 2023 |
MYH7 in cardiomyopathy and skeletal muscle myopathy.
Gao Y, Peng L, Zhao C |
Molecular and Cellular Biochemistry | 2023 |
Transforming Growth Factor-β Analysis of the VANISH Trial Cohort.
Kim Y, Mastali M, Van Eyk JE, Orav EJ, Vissing CR, Day SM, Axelsson Raja A, Russell MW, Zahka K, Lever HM, Pereira AC, Murphy AM, Canter C, Bach RG, Wheeler MT, Rossano JW, Owens AT, Bundgaard H, Benson L, Mestroni L, Taylor MRG, Patel AR, Wilmot I, Thrush P, Soslow JH, Becker JR, Seidman CE, Ho CY |
Circulation. Heart failure | 2023 |
Stage-specific therapy for hypertrophic cardiomyopathy
Argirò A, Zampieri M, Marchi A, Cappelli F, Del Franco A, Mazzoni C, Cecchi F, Olivotto I |
2023 | |
Trends in worldwide research on cardiac fibrosis over the period 1989–2022: a bibliometric study
Mao Y, Fu Q, Su F, Zhang W, Zhang Z, Zhou Y, Yang C |
Frontiers in Cardiovascular Medicine | 2023 |
Mechanisms and prognostic impact of myocardial ischaemia in hypertrophic cardiomyopathy.
Coleman JA, Ashkir Z, Raman B, Bueno-Orovio A |
The International Journal of Cardiovascular Imaging | 2023 |
p53 Regulates the Extent of Fibroblast Proliferation and Fibrosis in Left Ventricle Pressure Overload.
Liu X, Burke RM, Lighthouse JK, Baker CD, Dirkx RA Jr, Kang B, Chakraborty Y, Mickelsen DM, Twardowski JJ, Mello SS, Ashton JM, Small EM |
Circulation research | 2023 |
Chronic activation of human cardiac fibroblasts in vitro attenuates the reversibility of the myofibroblast phenotype.
Hall C, Law JP, Reyat JS, Cumberland MJ, Hang S, Vo NTN, Raniga K, Weston CJ, O'Shea C, Townend JN, Gehmlich K, Ferro CJ, Denning C, Pavlovic D |
Scientific Reports | 2023 |
Prognostic and Safety Implications of Renin-Angiotensin-Aldosterone System Inhibitors in Hypertrophic Cardiomyopathy: A Real-World Observation Over 2,000 Patients
Park CS, Rhee TM, Lee HJ, Yoon YE, Park JB, Lee SP, Kim YJ, Cho GY, Hwang IC, Kim HK |
Korean Circulation Journal | 2023 |
Myocardial Fibrosis in Hypertrophic Cardiomyopathy: A Perspective from Fibroblasts
Schlittler M, Pramstaller PP, Rossini A, De Bortoli M |
International journal of molecular sciences | 2023 |
The role of periostin in cardiac fibrosis.
Qiao B, Liu X, Wang B, Wei S |
Heart Failure Reviews | 2023 |
Periostin is overexpressed, correlated with fibrosis and differs among grades of cardiomyocyte hypertrophy in myectomy tissue of patients with hypertrophic cardiomyopathy
Ioakeimidis NS, Pitsis A, Zegkos T, Ntelios D, Kelpis T, Papamitsou T, Parcharidou D, Gossios T, Efthimiadis G, Meditskou S |
PloS one | 2023 |
MDM2 Regulation of HIF Signaling Causes Microvascular Dysfunction in Hypertrophic Cardiomyopathy
Shridhar P, Glennon MS, Pal S, Waldron CJ, Chetkof EJ, Basak P, Clavere NG, Banerjee D, Gingras S, Becker JR |
Circulation | 2023 |
Integrating mechanical cues with engineered platforms to explore cardiopulmonary development and disease
Ahmed DW, Eiken MK, DePalma SJ, Helms AS, Zemans RL, Spence JR, Baker BM, Loebel C |
iScience | 2023 |
Inhibition of miR-199a-3p in a murine hypertrophic cardiomyopathy (HCM) model attenuates fibrotic remodeling
Zalivina I, Barwari T, Yin X, Langley SR, Barallobre-Barreiro J, Wakimoto H, Zampetaki A, Mayr M, Avkiran M, Eminaga S |
2023 | |
Transflammation in Tissue Regeneration and Response to Injury: How cell-autonomous inflammatory signaling mediates cell plasticity
Cooke JP, Lai L |
Advanced Drug Delivery Reviews | 2023 |
FAM114A1 Influences Cardiac Pathological Remodeling by Regulating Angiotensin II Signaling
Kadiam C Venkata Subbaiah, Jiangbin Wu, W.H. Wilson Tang, Peng Yao |
JCI Insight | 2022 |
Transforming growth factor-β in myocardial disease
NG Frangogiannis |
Nature Reviews Cardiology | 2022 |
Pharmacological Management of Hypertrophic Cardiomyopathy: From Bench to Bedside
Palandri C, Santini L, Argirò A, Margara F, Doste R, Bueno-Orovio A, Olivotto I, Coppini R |
Drugs | 2022 |
Copper chelation in patients with hypertrophic cardiomyopathy
Reid A, Miller C, Farrant JP, Polturi R, Clark D, Ray S, Cooper G, Schmitt M |
Open Heart | 2022 |
Exploring the Communal Pathogenesis, Ferroptosis Mechanism, and Potential Therapeutic Targets of Dilated Cardiomyopathy and Hypertrophic Cardiomyopathy via a Microarray Data Analysis
Wang Z, Xia Q, Su W, Cao M, Sun Y, Zhang M, Chen W, Jiang T |
Frontiers in Cardiovascular Medicine | 2022 |
Postnatal Deletion of Bmal1 in Cardiomyocyte Promotes Pressure Overload Induced Cardiac Remodeling in Mice.
Liang Q, Xu H, Liu M, Qian L, Yan J, Yang G, Chen L |
Journal of the American Heart Association | 2022 |
ChGn-2 Plays a Cardioprotective Role in Heart Failure Caused by Acute Pressure Overload.
Haryono A, Ikeda K, Nugroho DB, Ogata T, Tsuji Y, Matoba S, Moriwaki K, Kitagawa H, Igarashi M, Hirata KI, Emoto N |
Journal of the American Heart Association | 2022 |
Ablation of lysophosphatidic acid receptor 1 attenuates hypertrophic cardiomyopathy in a mouse model.
Axelsson Raja A, Wakimoto H, DeLaughter DM, Reichart D, Gorham J, Conner DA, Lun M, Probst CK, Sakai N, Knipe RS, Montesi SB, Shea B, Adam LP, Leinwand LA, Wan W, Choi ES, Lindberg EL, Patone G, Noseda M, Hübner N, Seidman CE, Tager AM, Seidman JG, Ho CY |
Proceedings of the National Academy of Sciences | 2022 |
CDC-like kinase 4 deficiency contributes to pathological cardiac hypertrophy by modulating NEXN phosphorylation.
Huang J, Wang L, Shen Y, Zhang S, Zhou Y, Du J, Ma X, Liu Y, Liang D, Shi D, Ma H, Li L, Zhang Q, Chen YH |
Nature Communications | 2022 |
Transcriptional bursts and heterogeneity among cardiomyocytes in hypertrophic cardiomyopathy.
Burkart V, Kowalski K, Aldag-Niebling D, Beck J, Frick DA, Holler T, Radocaj A, Piep B, Zeug A, Hilfiker-Kleiner D, Dos Remedios CG, van der Velden J, Montag J, Kraft T |
Frontiers in Cardiovascular Medicine | 2022 |
Hypertrophic cardiomyopathy: Mutations to mechanisms to therapies
Kawana M, Spudich JA, Ruppel KM |
Frontiers in physiology | 2022 |
Maternal perfluorooctane sulfonic acid exposure during rat pregnancy causes hypersensitivity to angiotensin II and attenuation of endothelium-dependent vasodilation in the uterine arteries †.
Dangudubiyyam SV, Mishra JS, Song R, Kumar S |
Biology of reproduction | 2022 |
Contemporary Therapies and Future Directions in the Management of Hypertrophic Cardiomyopathy.
Packard E, de Feria A, Peshin S, Reza N, Owens AT |
Cardiology and Therapy | 2022 |
Defects in the Proteome and Metabolome in Human Hypertrophic Cardiomyopathy
Previs MJ, O\u2019Leary TS, Morley MP, Palmer B, LeWinter M, Yob J, Pagani FD, Petucci C, Kim MS, Margulies KB, Arany Z, Kelly DP, Day SM |
Circulation. Heart failure | 2022 |
Proteomics profiling reveals a distinct high-risk molecular subtype of hypertrophic cardiomyopathy
Liang LW, Raita Y, Hasegawa K, Fifer MA, Maurer MS, Reilly MP, Shimada YJ |
Heart (British Cardiac Society) | 2022 |
Defining the timeline of periostin upregulation in cardiac fibrosis following acute myocardial infarction in mice.
Gil H, Goldshtein M, Etzion S, Elyagon S, Hadad U, Etzion Y, Cohen S |
Scientific Reports | 2022 |
What Causes Hypertrophic Cardiomyopathy?
Maron BA, Wang RS, Carnethon MR, Rowin EJ, Loscalzo J, Maron BJ, Maron MS |
The American Journal of Cardiology | 2022 |
Transcriptional regulation of cardiac fibroblast phenotypic plasticity
Burgos Villar KN, Liu X, Small EM |
Current Opinion in Physiology | 2022 |
Lumican accumulates with fibrillar collagen in fibrosis in hypertrophic cardiomyopathy
Rixon C, Andreassen K, Shen X, Erusappan PM, Almaas VM, Palmero S, Dahl CP, Ueland T, Sjaastad I, Louch WE, Stokke MK, Tønnessen T, Christensen G, Lunde IG |
ESC Heart Failure | 2022 |
Fibroblasts orchestrate cellular crosstalk in the heart through the ECM
Bowers SL, Meng Q, Molkentin JD |
2022 | |
Individualized interactomes for network-based precision medicine in hypertrophic cardiomyopathy with implications for other clinical pathophenotypes
BA Maron, RS Wang, S Shevtsov, SG Drakos, E Arons, O Wever-Pinzon, GS Huggins, AO Samokhin, WM Oldham, Y Aguib, MH Yacoub, EJ Rowin, BJ Maron, MS Maron, J Loscalzo |
Nature Communications | 2021 |
LAMP2 Cardiomyopathy: Consequences of Impaired Autophagy in the Heart
R Alcalai, M Arad, H Wakimoto, D Yadin, J Gorham, L Wang, E Burns, BJ Maron, WC Roberts, T Konno, DA Conner, AR PerezAtayde, JG Seidman, CE Seidman |
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease | 2021 |
Shared Molecular Mechanisms of Hypertrophic Cardiomyopathy and Its Clinical Presentations: Automated Molecular Mechanisms Extraction Approach
M Glavaški, L Velicki |
Life Sciences | 2021 |
Valsartan in early-stage hypertrophic cardiomyopathy: a randomized phase 2 trial
CY Ho, SM Day, A Axelsson, MW Russell, K Zahka, HM Lever, AC Pereira, SD Colan, R Margossian, AM Murphy, C Canter, RG Bach, MT Wheeler, JW Rossano, AT Owens, H Bundgaard, L Benson, L Mestroni, MR Taylor, AR Patel, I Wilmot, P Thrush, JD Vargas, JH Soslow, JR Becker, CE Seidman, NK Lakdawala, AL Cirino, JE Krieger, L Sacilotto, E Arteaga, MO Antunes, EK Hall, L Choudhury, E Pahl, KY Lin, GD Lewis, AS Desai, KM Burns, JJ McMurray, CA MacRae, SD Solomon, EJ Orav, E Braunwald |
Nature Medicine | 2021 |
Single-Cell RNA Sequencing Uncovers Paracrine Functions of the Epicardial-Derived Cells in Arrhythmogenic Cardiomyopathy
P Yuan, SM Cheedipudi, L Rouhi, S Fan, L Simon, Z Zhao, K Hong, P Gurha, AJ Marian |
Circulation | 2021 |
Yes-Associated Protein (Yap) Is Up-Regulated in Heart Failure and Promotes Cardiac Fibroblast Proliferation
M Sharifi-Sanjani, M Berman, D Goncharov, M Alhamaydeh, TG Avolio, J Baust, B Chang, A Kobir, M Ross, CS Croix, SM Nouraie, CF McTiernan, CS Moravec, E Goncharova, IA Ghouleh |
International journal of molecular sciences | 2021 |
Molecular Genetic Basis of Hypertrophic Cardiomyopathy
AJ Marian |
Circulation research | 2021 |
Immune Cells and Immunotherapy for Cardiac Injury and Repair
JG Rurik, H Aghajanian, JA Epstein |
Circulation research | 2021 |
A Dual Role for Death Receptor 5 in Regulating Cardiac Fibroblast Function
MA Tanner, LA Grisanti |
Frontiers in Cardiovascular Medicine | 2021 |
Effect of sarcomere and mitochondria-related mutations on myocardial fibrosis in patients with hypertrophic cardiomyopathy
H Chung, Y Kim, CH Park, JY Kim, PK Min, YW Yoon, TH Kim, BK Lee, BK Hong, SJ Rim, HM Kwon, KA Lee, EY Choi |
Journal of Cardiovascular Magnetic Resonance | 2021 |
Targeting mitochondrial reactive oxygen species-mediated oxidative stress attenuates nicotine-induced cardiac remodeling and dysfunction
A Ramalingam, SB Budin, NM Fauzi, RH Ritchie, S Zainalabidin |
Scientific Reports | 2021 |
MicroRNA‑331 inhibits isoproterenol‑induced expression of profibrotic genes in cardiac myofibroblasts via the TGFβ/smad3 signaling pathway
F Yousefi, BM Soltani, S Rabbani |
Scientific Reports | 2021 |
Electrophysiological and Structural Remodeling of the Atria in a Mouse Model of Troponin-I Mutation Linked Hypertrophic Cardiomyopathy: Implications for Atrial Fibrillation
WW Lim, M Neo, S Thanigaimani, P Kuklik, AN Ganesan, DH Lau, T Tsoutsman, JM Kalman, C Semsarian, DA Saint, P Sanders |
International journal of molecular sciences | 2021 |
Effects of Angiotensin II Receptor Blockers on Ventricular Hypertrophy in Hypertrophic Cardiomyopathy: A Meta-Analysis of Randomized Controlled Trials
Y Liu, K Teramoto, VK Wing, T Supasiri, K Yin |
Cardiovascular Drugs and Therapy | 2021 |
Gene Expression Classifier Reveals Prognostic Osteosarcoma Microenvironment Molecular Subtypes
YJ Song, Y Xu, C Deng, X Zhu, J Fu, H Chen, J Lu, H Xu, G Song, Q Tang, J Wang |
Frontiers in immunology | 2021 |
ELTD1 Activation Induces an Endothelial-EMT Transition to a Myofibroblast Phenotype
H Sheldon, J Alexander, E Bridges, L Moreira, S Reilly, KH Ang, D Wang, S Lin, S Haider, AH Banham, AL Harris |
International journal of molecular sciences | 2021 |
An Insight on Multicentric Signaling of Angiotensin II in Cardiovascular system: A Recent Update
K Verma, M Pant, S Paliwal, J Dwivedi, S Sharma |
Frontiers in pharmacology | 2021 |
Interplay of Genotype and Substrate Stiffness in Driving the Hypertrophic Cardiomyopathy Phenotype in iPSC-Micro-Heart Muscle Arrays
J Guo, H Jiang, K Oguntuyo, B Rios, Z Boodram, N Huebsch |
Cellular and Molecular Bioengineering | 2021 |
Complex Relationship Between Cardiac Fibroblasts and Cardiomyocytes in Health and Disease
C Hall, K Gehmlich, C Denning, D Pavlovic |
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease | 2021 |
Biological Mechanisms and Therapeutic Opportunities in Mammographic Density and Breast Cancer Risk
M Archer, P Dasari, A Evdokiou, WV Ingman |
Cancers | 2021 |
The role of microRNAs in diseases and related signaling pathways
A Vaghf, B Khansarinejad, E Ghaznavi-Rad, M Mondanizadeh |
Molecular Biology Reports | 2021 |
Sacubitril/Valsartan Inhibits Cardiomyocyte Hypertrophy in Angiotensin II-Induced Hypertensive Mice Independent of a Blood Pressure-Lowering Effect
K Tashiro, T Kuwano, A Ideishi, H Morita, Y Idemoto, M Goto, Y Suematsu, S Miura |
Cardiology Research | 2020 |
The Dynamic Interplay Between Cardiac Inflammation and Fibrosis
TP Thomas, LA Grisanti |
Frontiers in physiology | 2020 |
Small Molecules Acting on Myofilaments as Treatments for Heart and Skeletal Muscle Diseases
K Alsulami, S Marston |
International journal of molecular sciences | 2020 |
Targeting cardiac fibrosis in heart failure with preserved ejection fraction: mirage or miracle?
M Sweeney, B Corden, SA Cook |
EMBO Molecular Medicine | 2020 |
Respiratory chain signalling is essential for adaptive remodelling following cardiac ischaemia
M Szibor, R Schreckenberg, Z Gizatullina, E Dufour, M Wiesnet, PK Dhandapani, G DebskaVielhaber, J Heidler, I Wittig, TA Nyman, U Gärtner, AR Hall, V Pell, C Viscomi, T Krieg, MP Murphy, T Braun, FN Gellerich, KD Schlüter, HT Jacobs |
Journal of Cellular and Molecular Medicine | 2020 |
Stochastic allelic expression as trigger for contractile imbalance in hypertrophic cardiomyopathy
J Montag, T Kraft |
Biophysical Reviews | 2020 |
Glutamyl-Prolyl-tRNA Synthetase Regulates Proline-Rich Pro-Fibrotic Protein Synthesis During Cardiac Fibrosis
J Wu, KC Subbaiah, LH Xie, F Jiang, ES Khor, D Mickelsen, JR Myers, WH Tang, P Yao |
Circulation research | 2020 |
Hypertrophic cardiomyopathy
M de Oliveira Antunes, TL Scudeler |
IJC Heart & Vasculature | 2020 |
Myosin Sequestration Regulates Sarcomere Function, Cardiomyocyte Energetics, and Metabolism, Informing the Pathogenesis of Hypertrophic Cardiomyopathy
CN Toepfer, AC Garfinkel, G Venturini, H Wakimoto, G Repetti, L Alamo, A Sharma, R Agarwal, JF Ewoldt, P Cloonan, J Letendre, M Lun, I Olivotto, S Colan, E Ashley, D Jacoby, M Michels, CS Redwood, HC Watkins, SM Day, JF Staples, R Padrón, A Chopra, CY Ho, CS Chen, AC Pereira, JG Seidman, CE Seidman |
Circulation | 2020 |
Burden of premature ventricular contractions beyond nonsustained ventricular tachycardia is related to the myocardial extracellular space expansion in patients with hypertrophic‐cardiomyopathy
H Chung, CH Park, Y Kim, JY Kim, PK Min, YW Yoon, KA Lee, BK Lee, BK Hong, TH Kim, SJ Rim, HM Kwon, EY Choi |
Clinical Cardiology | 2020 |
Anti-integrin αv therapy improves cardiac fibrosis after myocardial infarction by blunting cardiac PW1+ stromal cells
M Bouvet, O Claude, M Roux, D Skelly, N Masurkar, N Mougenot, S Nadaud, C Blanc, C Delacroix, S Chardonnet, C Pionneau, C Perret, E Yaniz-Galende, N Rosenthal, DA Trégouët, G Marazzi, JS Silvestre, D Sassoon, JS Hulot |
Scientific Reports | 2020 |
Unraveling the Genotype‐Phenotype Relationship in Hypertrophic Cardiomyopathy: Obesity‐Related Cardiac Defects as a Major Disease Modifier
EE Nollet, BD Westenbrink, RA de Boer, DW Kuster, J van der Velden |
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease | 2020 |
A Novel Bespoke Hypertrophic Scar Treatment: Actualizing Hybrid Pressure and Silicone Therapies with 3D Printing and Scanning
L Chow, K Yick, Y Sun, MS Leung, M Kwan, S Ng, A Yu, J Yip, Y Chan |
International journal of bioprinting | 2020 |
Impact of dietary fat and sucrose consumption on cardiac fibrosis in mice and rhesus monkeys
Niranjana Natarajan, Ana Vujic, Jishnu Das, Annie C Wang, Krystal K Phu, Spencer H Kiehm, Elisabeth M Ricci-Blair, Anthony Y Zhu, Kelli L. Vaughan, Julie A. Mattison, Ricki J. Colman, Richard Lee |
JCI Insight | 2019 |
Three in a Box: Understanding Cardiomyocyte, Fibroblast, and Innate Immune Cell Interactions to Orchestrate Cardiac Repair Processes
S Psarras, D Beis, S Nikouli, M Tsikitis, Y Capetanaki |
Frontiers in Cardiovascular Medicine | 2019 |
Cardiac Fibroblasts and the Extracellular Matrix in Regenerative and Nonregenerative Hearts
L Hortells, AK Johansen, KE Yutzey |
Journal of Cardiovascular Development and Disease | 2019 |
Stachydrine Ameliorates Cardiac Fibrosis Through Inhibition of Angiotensin II/Transformation Growth Factor β1 Fibrogenic Axis
X Liu, X Shan, H Chen, Z Li, P Zhao, C Zhang, W Guo, M Xu, R Lu |
Frontiers in pharmacology | 2019 |
An integrative systems approach identifies novel candidates in Marfan syndrome-related pathophysiology
R Bhushan, L Altinbas, M Jäger, M Zaradzki, D Lehmann, B Timmermann, NP Clayton, Y Zhu, K Kallenbach, G Kararigas, PN Robinson |
Journal of Cellular and Molecular Medicine | 2019 |
DNA Damage Response/TP53 Pathway Is Activated and Contributes to the Pathogenesis of Dilated Cardiomyopathy Associated with Lamin A/C Mutations
SN Chen, R Lombardi, J Karmouch, JY Tsai, GZ Czernuszewicz, M Taylor, L Mestroni, C Coarfa, P Gurha, AJ Marian |
Circulation research | 2019 |
Hypertrophic cardiomyopathy: genetics and clinical perspectives
CM Wolf |
Cardiovascular diagnosis and therapy | 2019 |
Widespread Translational Control of Fibrosis in the Human Heart by RNA-Binding Proteins
S Chothani, S Schäfer, E Adami, S Viswanathan, AA Widjaja, SR Langley, J Tan, M Wang, NM Quaife, CJ Pua, G D'Agostino, SG Shekeran, BL George, S Lim, EY Cao, S van Heesch, F Witte, LE Felkin, EG Christodoulou, J Dong, S Blachut, G Patone, PJ Barton, N Hubner, SA Cook, OJ Rackham |
Circulation | 2019 |
The Extracellular Matrix in Ischemic and Nonischemic Heart Failure
NG Frangogiannis |
Circulation research | 2019 |
Altered force generation and cell-to-cell contractile imbalance in hypertrophic cardiomyopathy
T Kraft, J Montag |
Pflügers Archiv - European Journal of Physiology | 2019 |
Metabolic Changes in Spontaneously Hypertensive Rat Hearts Precede Cardiac Dysfunction and Left Ventricular Hypertrophy
J Li, BA Kemp, NL Howell, J Massey, K Mińczuk, Q Huang, MD Chordia, RJ Roy, JT Patrie, GE Davogustto, CM Kramer, FH Epstein, RM Carey, H Taegtmeyer, SR Keller, BK Kundu |
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease | 2019 |
Does the Flow Know? Mitral Regurgitant Jet Direction and Need for Valve Repair in Hypertrophic Obstructive Cardiomyopathy
E Schwammenthal, AA Hagège, RA Levine |
Journal of the American Society of Echocardiography | 2019 |
miR‑216a exacerbates TGF‑β‑induced myofibroblast transdifferentiation via PTEN/AKT signaling
C Qu, X Liu, T Ye, L Wang, S Liu, X Zhou, G Wu, J Lin, S Shi, B Yang |
Molecular medicine reports | 2019 |
Co‑culturing with hypoxia pre‑conditioned mesenchymal stem cells as a new strategy for the prevention of irradiation‑induced fibroblast‑to‑myofibroblast transition
L Zhuang, W Xia, M Hou |
Oncology reports | 2019 |
Long-term outcomes of childhood onset Noonan compared to sarcomere hypertrophic cardiomyopathy
E Kaltenecker, J Schleihauf, C Meierhofer, N Shehu, N Mkrtchyan, A Hager, A Kühn, J Cleuziou, K Klingel, H Seidel, M Zenker, P Ewert, G Hessling, CM Wolf |
Cardiovascular diagnosis and therapy | 2019 |
The relationship between myocardial fibrosis detected by cardiac magnetic resonance and Tp‐e interval, 5‐year sudden cardiac death risk score in hypertrophic cardiomyopathy patients
AR Demir, Ö Celik, S Sevinç, B Uygur, S Kahraman, E Yilmaz, M Cemek, Y Onal, M Erturk |
Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc | 2019 |
Baseline Characteristics of the VANISH Cohort
AA Raja, L Shi, SM Day, M Russell, K Zahka, H Lever, SD Colan, R Margossian, EK Hall, J Becker, JL Jefferies, AR Patel, L Choudhury, AM Murphy, C Canter, R Bach, M Taylor, L Mestroni, MT Wheeler, L Benson, AT Owens, J Rossano, KY Lin, E Pahl, AC Pereira, H Bundgaard, GD Lewis, JD Vargas, AL Cirino, JJ McMurray, CA MacRae, SD Solomon, EJ Orav, E Braunwald, CY Ho |
Circulation. Heart failure | 2019 |
Myocardial fibrosis, inflammation, and altered cardiac gene expression profiles in rats exposed to a predator-based model of posttraumatic stress disorder
BR Rorabaugh, NW Mabe, SL Seeley, TS Stoops, KE Mucher, CP Ney, CS Goodman, BJ Hertenstein, AE Rush, CD Kasler, AM Sargeant, PR Zoladz |
Stress (Amsterdam, Netherlands) | 2019 |
Allele-specific differences in transcriptome, miRNome, and mitochondrial function in two hypertrophic cardiomyopathy mouse models
Styliani Vakrou, Ryuya Fukunaga, D. Brian Foster, Lars Sorensen, Yamin Liu, Yufan Guan, Kirubel Woldemichael, Roberto Pineda-Reyes, Ting Liu, Jil Tardiff, Leslie Leinwand, Carlo G. Tocchetti, Theodore Abraham, Brian O'Rourke, Miguel A. Aon, M. Roselle Abraham |
JCI Insight | 2018 |
Testosterone plays a permissive role in angiotensin II-induced hypertension and cardiac hypertrophy in male rats†
JS Mishra, AS More, K Gopalakrishnan, S Kumar |
Biology of reproduction | 2018 |
miR-133: A Suppressor of Cardiac Remodeling?
N Li, H Zhou, Q Tang |
Frontiers in pharmacology | 2018 |
PIMT/NCOA6IP Deletion in the Mouse Heart Causes Delayed Cardiomyopathy Attributable to Perturbation in Energy Metabolism
Y Jia, N Liu, N Viswakarma, R Sun, M Schipma, M Shang, E Thorp, Y Kanwar, B Thimmapaya, J Reddy |
International journal of molecular sciences | 2018 |
Myofibroblast-Specific TGFβ Receptor II Signaling in the Fibrotic Response to Cardiac Myosin Binding Protein C-Induced Cardiomyopathy
Q Meng, B Bhandary, S Bhuiyan, J James, H Osinska, I Valiente-Alandi, K Shay-Winkler, J Gulick, JD Molkentin, BC Blaxall, J Robbins |
Circulation research | 2018 |
Gr-1+ Cells Other Than Ly6G+ Neutrophils Limit Virus Replication and Promote Myocardial Inflammation and Fibrosis Following Coxsackievirus B3 Infection of Mice
D Xu, P Wang, J Yang, Q Qian, M Li, L Wei, W Xu |
Frontiers in Cellular and Infection Microbiology | 2018 |
Transient fibrosis resolves via fibroblast inactivation in the regenerating zebrafish heart
H Sánchez-Iranzo, M Galardi-Castilla, A Sanz-Morejón, JM González-Rosa, R Costa, A Ernst, JS de Aja, X Langa, N Mercader |
Proceedings of the National Academy of Sciences | 2018 |
Successful knock-in of Hypertrophic Cardiomyopathy-mutation R723G into the MYH7 gene mimics HCM pathology in pigs
J Montag, B Petersen, AK Flögel, E Becker, A Lucas-Hahn, GJ Cost, C Mühlfeld, T Kraft, H Niemann, B Brenner |
Scientific Reports | 2018 |
Metabolic changes in hypertrophic cardiomyopathies: scientific update from the Working Group of Myocardial Function of the European Society of Cardiology
J van der Velden, CG Tocchetti, G Varricchi, A Bianco, V Sequeira, D Hilfiker-Kleiner, N Hamdani, AF Leite-Moreira, M Mayr, I Falcão-Pires, T Thum, DK Dawson, JL Balligand, S Heymans |
Cardiovascular Research | 2018 |
Region of Interest analysis using mass spectrometry imaging of mitochondrial and sarcomeric proteins in acute cardiac infarction tissue
Y Yajima, T Hiratsuka, Y Kakimoto, S Ogawa, K Shima, Y Yamazaki, K Yoshikawa, K Tamaki, T Tsuruyama |
Scientific Reports | 2018 |
Burst-Like Transcription of Mutant and Wildtype MYH7-Alleles as Possible Origin of Cell-to-Cell Contractile Imbalance in Hypertrophic Cardiomyopathy
J Montag, K Kowalski, M Makul, P Ernstberger, A Radocaj, J Beck, E Becker, S Tripathi, B Keyser, C Mühlfeld, K Wissel, A Pich, J van der Velden, CG dos Remedios, A Perrot, A Francino, F Navarro-López, B Brenner, T Kraft |
Frontiers in physiology | 2018 |
Hypertrophy Regression With N-Acetylcysteine in Hypertrophic Cardiomyopathy (HALT-HCM)Novelty and Significance: A Randomized, Placebo-Controlled, Double-Blind Pilot Study
AJ Marian, Y Tan, L Li, J Chang, P Syrris, M Hessabi, MH Rahbar, JT Willerson, BY Cheong, CY Liu, NS Kleiman, DA Bluemke, SF Nagueh |
Circulation research | 2018 |
Biomarkers of Myocardial Fibrosis: Revealing the Natural History of Fibrogenesis in Fabry Disease Cardiomyopathy
P Aguiar, O Azevedo, R Pinto, J Marino, C Cardoso, N Sousa, D Cunha, D Hughes, JL Soares |
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease | 2018 |
Genotype and Lifetime Burden of Disease in Hypertrophic Cardiomyopathy: Insights From the Sarcomeric Human Cardiomyopathy Registry (SHaRe)
CY Ho, SM Day, EA Ashley, M Michels, AC Pereira, D Jacoby, AL Cirino, JC Fox, NK Lakdawala, JS Ware, CA Caleshu, AS Helms, SD Colan, F Girolami, F Cecchi, CE Seidman, G Sajeev, J Signorovitch, EM Green, I Olivotto |
Circulation | 2018 |
Cardiac Fibrosis in Proteotoxic Cardiac Disease is Dependent Upon Myofibroblast TGF‐β Signaling
B Bhandary, Q Meng, J James, H Osinska, J Gulick, I ValienteAlandi, MA Sargent, S Bhuiyan, BC Blaxall, JD Molkentin, J Robbins |
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease | 2018 |
Progression of myocardial fibrosis in hypertrophic cardiomyopathy: mechanisms and clinical implications
B Raman, R Ariga, M Spartera, S Sivalokanathan, K Chan, S Dass, SE Petersen, MJ Daniels, J Francis, R Smillie, AJ Lewandowski, EO Ohuma, C Rodgers, CM Kramer, M Mahmod, H Watkins, S Neubauer |
European Heart Journal - Cardiovascular Imaging | 2018 |
Histone lysine dimethyl-demethylase KDM3A controls pathological cardiac hypertrophy and fibrosis
QJ Zhang, TA Tran, M Wang, MJ Ranek, KM Kokkonen-Simon, J Gao, X Luo, W Tan, V Kyrychenko, L Liao, J Xu, JA Hill, EN Olson, DA Kass, ED Martinez, ZP Liu |
Nature Communications | 2018 |
Fibroblast-specific genetic dissection of TGFbeta-Smad2/3 signaling in cardiac fibrosis
Hadi Khalil, Onur kanisicak, Vikram Prasad, Robert, Nathan Correll, Xing Fu, Tobias Schips, Ronald Vagnozzi, Ruijie Liu, Thanh Huynh, Se-Jin Lee, Jason Karch, Jeffrey D. Molkentin |
Journal of Clinical Investigation | 2017 |
Nonmyocyte ERK1/2 Signaling Contributes to Load-Induced Cardiomyopathy in Marfan Mice
Rosanne Rouf, Elena Gallo MacFarlane, Eiki Takimoto, Rahul Chaudhary, Varun Nagpal, Peter Rainer, Julia G. Bindman, Elizabeth E. Gerber, Djahida Bedja, Christopher Schiefer, Karen Miller, Guangshuo Zhu, Loretha Myers, Nuria Amat-Alarcon, Dong I. Lee, Norimichi Koitabashi, Daniel P. Judge, David A. Kass, Harry C. Dietz, III |
JCI Insight | 2017 |
New Role for Interleukin‐13 Receptor α1 in Myocardial Homeostasis and Heart Failure
U Amit, D Kain, A Wagner, A Sahu, Y NevoCaspi, N Gonen, N Molotski, T Konfino, N Landa, N NaftaliShani, G Blum, E Merquiol, D KaroAtar, Y Kanfi, G Paret, A Munitz, HY Cohen, E Ruppin, S Hannenhalli, J Leor |
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease | 2017 |
Cardiovascular homeostasis dependence on MICU2, a regulatory subunit of the mitochondrial calcium uniporter
AG Bick, H Wakimoto, KJ Kamer, Y Sancak, O Goldberger, A Axelsson, DM DeLaughter, JM Gorham, VK Mootha, JG Seidman, CE Seidman |
Proceedings of the National Academy of Sciences | 2017 |
Th1 effector T cells selectively orchestrate cardiac fibrosis in nonischemic heart failure
T Nevers, AM Salvador, F Velazquez, N Ngwenyama, FJ Carrillo-Salinas, M Aronovitz, RM Blanton, P Alcaide |
Journal of Experimental Medicine | 2017 |
Molecular Characterization of Pediatric Restrictive Cardiomyopathy from Integrative Genomics
TN Rindler, RB Hinton, N Salomonis, SM Ware |
Scientific Reports | 2017 |
Differential regulation of miRNA and mRNA expression in the myocardium of Nrf2 knockout mice
JM Quiles, M Narasimhan, G Shanmugam, B Milash, JR Hoidal, NS Rajasekaran |
BMC Genomics | 2017 |
Emerging pharmacologic and structural therapies for hypertrophic cardiomyopathy
DJ Philipson, EC DePasquale, EH Yang, AS Baas |
Heart Failure Reviews | 2017 |
Hypertrophic Cardiomyopathy: Genetics, Pathogenesis, Clinical Manifestations, Diagnosis, and Therapy
AJ Marian, E Braunwald |
Circulation research | 2017 |
Pediatric Cardiomyopathies
TM Lee, DT Hsu, P Kantor, JA Towbin, SM Ware, SD Colan, WK Chung, JL Jefferies, JW Rossano, CD Castleberry, LJ Addonizio, AK Lal, JM Lamour, EM Miller, PT Thrush, JD Czachor, H Razoky, A Hill, SE Lipshultz |
Circulation research | 2017 |
TGF-β-Induced Endothelial-Mesenchymal Transition in Fibrotic Diseases
E Pardali, G Sanchez-Duffhues, M Gomez-Puerto, P Dijke |
International journal of molecular sciences | 2017 |
Pathophysiology of Aortic Valve Stenosis: Is It Both Fibrocalcific and Sex Specific?
Y Sritharen, M Enriquez-Sarano, HV Schaff, G Casaclang-Verzosa, JD Miller |
Physiology (Bethesda, Md.) | 2017 |
Luteolin-7-diglucuronide attenuates isoproterenol-induced myocardial injury and fibrosis in mice
B Ning, Y Zhang, D Wu, J Cui, L Liu, P Wang, W Wang, W Zhu, Y Chen, T Zhang |
Acta Pharmacologica Sinica | 2017 |
Myocardial fibrosis: biomedical research from bench to bedside: Myocardial fibrosis: biomedical research from bench to bedside
M Gyöngyösi, J Winkler, I Ramos, QT Do, H Firat, K McDonald, A González, T Thum, J Díez, F Jaisser, A Pizard, F Zannad |
European Journal of Heart Failure | 2017 |
Biophysical properties of human β-cardiac myosin with converter mutations that cause hypertrophic cardiomyopathy
M Kawana, SS Sarkar, S Sutton, KM Ruppel, JA Spudich |
Science Advances | 2017 |
Valsartan for Attenuating Disease Evolution in Early Sarcomeric Hypertrophic Cardiomyopathy: The Design of the VANISH Trial
CY Ho, JJ McMurray, AL Cirino, SD Colan, SM Day, AS Desai, SE Lipshultz, CA MacRae, L Shi, SD Solomon, EJ Orav, E Braunwald |
American Heart Journal | 2017 |
Cardiac Function Remains Impaired Despite Reversible Cardiac Remodeling after Acute Experimental Viral Myocarditis
PM Becher, F Gotzhein, K Klingel, F Escher, S Blankenberg, D Westermann, D Lindner |
Journal of Immunology Research | 2017 |
Cardiac Fibroblast Activation Post-Myocardial Infarction: Current Knowledge Gaps
Y Ma, RP Iyer, M Jung, MP Czubryt, ML Lindsey |
Trends in Pharmacological Sciences | 2017 |
Sexual dimorphism in the fetal cardiac response to maternal nutrient restriction
S Muralimanoharan, C Li, ES Nakayasu, CP Casey, TO Metz, PW Nathanielsz, A Maloyan |
Journal of Molecular and Cellular Cardiology | 2017 |
Lipoprotein(a) in patients with aortic stenosis: Insights from cardiovascular magnetic resonance
VS Vassiliou, PD Flynn, CE Raphael, S Newsome, T Khan, A Ali, B Halliday, AS Bruengger, T Malley, P Sharma, S Selvendran, N Aggarwal, A Sri, H Berry, J Donovan, W Lam, D Auger, SA Cook, DJ Pennell, SK Prasad, X Cheng |
PloS one | 2017 |
Olmesartan attenuates pressure-overload- or post-infarction-induced cardiac remodeling in mice
Q Wang, Z Chen, X Huang, L Chen, B Chen, Y Zhu, S Cao, W Liao, J Bin, M Kitakaze, Y Liao |
Oncotarget | 2017 |
Molecular Profiling of Dilated Cardiomyopathy that Progresses to Heart Failure
Michael Burke, Stephen Chang, Hiroko Wakimoto, Joshua Gorham, David Conner, Danos Christodoulou, Michael Parfenov, Steven DePalma, Seda Eminaga, Tetsuo Konno, Jonathan Seidman, Christine Seidman |
JCI Insight | 2016 |
Autonomous and Non-autonomous Defects Underlie Hypertrophic Cardiomyopathy in BRAF-Mutant hiPSC-Derived Cardiomyocytes
R Josowitz, S Mulero-Navarro, NA Rodriguez, C Falce, N Cohen, EM Ullian, LA Weiss, KA Rauen, EA Sobie, BD Gelb |
Stem Cell Reports | 2016 |
Integrating genetics and medicine: Disease-modifying treatment strategies for hypertrophic cardiomyopathy
CY Ho |
Progress in Pediatric Cardiology | 2016 |
Cardiac Fibrosis: The Fibroblast Awakens
JG Travers, FA Kamal, J Robbins, KE Yutzey, BC Blaxall |
Circulation research | 2016 |
Integrative Analysis of PRKAG2 Cardiomyopathy iPS and Microtissue Models Identifies AMPK as a Regulator of Metabolism, Survival, and Fibrosis
JT Hinson, A Chopra, A Lowe, CC Sheng, RM Gupta, R Kuppusamy, J O'Sullivan, G Rowe, H Wakimoto, J Gorham, K Zhang, K Musunuru, RE Gerszten, SM Wu, CS Chen, JG Seidman, CE Seidman |
Cell Reports | 2016 |
Relevance of mouse models of cardiac fibrosis and hypertrophy in cardiac research
V Rai, P Sharma, S Agrawal, DK Agrawal |
Molecular and Cellular Biochemistry | 2016 |
Cardiac Troponin and Tropomyosin: Structural and Cellular Perspectives to Unveil the Hypertrophic Cardiomyopathy Phenotype
MA Marques, GA de Oliveira |
Frontiers in physiology | 2016 |
Clinical and Mechanistic Insights Into the Genetics of Cardiomyopathy
MA Burke, SA Cook, JG Seidman, CE Seidman |
Journal of the American College of Cardiology | 2016 |
Transcriptional control of cardiac fibroblast plasticity
JK Lighthouse, EM Small |
Journal of Molecular and Cellular Cardiology | 2016 |
Downregulation of GSTK1 Is a Common Mechanism Underlying Hypertrophic Cardiomyopathy
S Sasagawa, Y Nishimura, S Okabe, S Murakami, Y Ashikawa, M Yuge, K Kawaguchi, R Kawase, R Okamoto, M Ito, T Tanaka |
Frontiers in pharmacology | 2016 |
Cardiovascular magnetic resonance detects the progression of impaired myocardial perfusion reserve and increased left-ventricular mass in mice fed a high-fat diet
NK Naresh, JT Butcher, RJ Lye, X Chen, BE Isakson, LM Gan, CM Kramer, BH Annex, FH Epstein |
Journal of Cardiovascular Magnetic Resonance | 2016 |
Cardiomyocyte-Specific Ablation of Med1 Subunit of the Mediator Complex Causes Lethal Dilated Cardiomyopathy in Mice
Y Jia, HC Chang, MJ Schipma, J Liu, V Shete, N Liu, T Sato, EB Thorp, PM Barger, YJ Zhu, N Viswakarma, YS Kanwar, H Ardehali, B Thimmapaya, JK Reddy, AS Lewin |
PloS one | 2016 |
Sexual dimorphism in activation of placental autophagy in obese women with evidence for fetal programming from a placenta-specific mouse model
S Muralimanoharan, X Gao, S Weintraub, L Myatt, A Maloyan |
Autophagy | 2016 |
Epicardium-derived fibroblasts in heart development and disease
M Fang, FL Xiang, CM Braitsch, KE Yutzey |
Journal of Molecular and Cellular Cardiology | 2016 |
Current Protocols in Molecular Biology: Cell Proliferation Markers in Paraffin-Embedded Sections
S Eminaga, P Teekakirikul, CE Seidman, JG Seidman |
Current Protocols in Molecular Biology: Cell Proliferation Markers in Paraffin-Embedded Sections | 2016 |
Periostin as a multifunctional modulator of the wound healing response
JT Walker, K McLeod, S Kim, SJ Conway, DW Hamilton |
Cell and Tissue Research | 2016 |
Kcne2 deletion attenuates acute post-ischaemia/reperfusion myocardial infarction
Z Hu, SM Crump, P Zhang, GW Abbott |
Cardiovascular Research | 2016 |
A small-molecule inhibitor of sarcomere contractility suppresses hypertrophic cardiomyopathy in mice
EM Green, H Wakimoto, RL Anderson, MJ Evanchik, JM Gorham, BC Harrison, M Henze, R Kawas, JD Oslob, HM Rodriguez, Y Song, W Wan, LA Leinwand, JA Spudich, RS McDowell, JG Seidman, CE Seidman |
Science | 2016 |
sFRP2 activates Wnt/β-catenin signaling in cardiac fibroblasts: differential roles in cell growth, energy metabolism, and extracellular matrix remodeling
H Lin, M Angeli, KJ Chung, C Ejimadu, AR Rosa, T Lee |
American journal of physiology. Cell physiology | 2016 |
Drug Therapy for Hypertrophic Cardiomypathy: Physiology and Practice
V. Sherrid M |
Current cardiology reviews | 2016 |
Increased Transforming Growth Factor-β Levels Associated With Cardiac Adverse Events in Hypertrophic Cardiomyopathy: High TGF-β worsens prognosis in HCM
B Ayça, I Sahin, SH Kucuk, F Akin, D Kafadar, M Avşar, II Avci, B Gungor, E Okuyan, MH Dinckal |
Clinical Cardiology | 2015 |
Integrated Glycoprotein Immobilization Method for Glycopeptide and Glycan Analysis of Cardiac Hypertrophy
S Yang, S Mishra, L Chen, J Zhou, DW Chan, S Chatterjee, H Zhang |
Analytical Chemistry | 2015 |
MiR-125b is Critical for Fibroblast-to-Myofibroblast Transition and Cardiac Fibrosis
V Nagpal, R Rai, AT Place, SB Murphy, SK Verma, AK Ghosh, DE Vaughan |
Circulation | 2015 |
Research priorities in sarcomeric cardiomyopathies
J der Velden, CY Ho, JC Tardiff, I Olivotto, BC Knollmann, L Carrier |
Cardiovascular Research | 2015 |
Targeted Mybpc3 Knock-Out Mice with Cardiac Hypertrophy Exhibit Structural Mitral Valve Abnormalities
D Judge, H Neamatalla, R Norris, R Levine, J Butcher, N Vignier, K Kang, Q Nguyen, P Bruneval, MC Perier, E Messas, X Jeunemaitre, A Vlaming, R Markwald, L Carrier, A Hagège |
Journal of Cardiovascular Development and Disease | 2015 |
Mitral valve disease—morphology and mechanisms
RA Levine, AA Hagége, DP Judge, M Padala, JP Dal-Bianco, E Aikawa, J Beaudoin, J Bischoff, N Bouatia-Naji, P Bruneval, JT Butcher, A Carpentier, M Chaput, AH Chester, C Clusel, FN Delling, HC Dietz, C Dina, R Durst, L Fernandez-Friera, MD Handschumacher, MO Jensen, XP Jeunemaitre, HL Marec, TL Tourneau, RR Markwald, J Mérot, E Messas, DP Milan, T Neri, RA Norris, D Peal, M Perrocheau, V Probst, M Pucéat, N Rosenthal, J Solis, JJ Schott, E Schwammenthal, SA Slaugenhaupt, JK Song, MH Yacoub |
Nature Reviews Cardiology | 2015 |
A Food-Derived Flavonoid Luteolin Protects against Angiotensin II-Induced Cardiac Remodeling
A Nakayama, H Morita, T Nakao, T Yamaguchi, T Sumida, Y Ikeda, H Kumagai, Y Motozawa, T Takahashi, A Imaizumi, T Hashimoto, R Nagai, I Komuro, LE Quintas |
PloS one | 2015 |
Immune Cell and Other Noncardiomyocyte Regulation of Cardiac Hypertrophy and Remodeling
RA Frieler, RM Mortensen |
Circulation | 2015 |
Heart Failure and Atrial Fibrillation: From Basic Science to Clinical Practice
J Ferreira, M Santos |
International journal of molecular sciences | 2015 |
Cardiac fibroblasts: from development to heart failure
T Moore-Morris, N Guimarães-Camboa, KE Yutzey, M Pucéat, SM Evans |
Journal of Molecular Medicine | 2015 |
INHERIT (INHibition of the renin angiotensin system in hypertrophic cardiomyopathy and the Effect on hypertrophy—a Randomised Intervention Trial with losartan)
I Olivotto, EA Ashley |
Global Cardiology Science and Practice | 2015 |
Towards causally cohesive genotype-phenotype modelling for characterization of the soft-tissue mechanics of the heart in normal and pathological geometries
O Nordbo, AB Gjuvsland, A Nermoen, S Land, S Niederer, P Lamata, J Lee, NP Smith, SW Omholt, JO Vik |
Journal of The Royal Society Interface | 2015 |
For whom the cells pull: Hydrogel and micropost devices for measuring traction forces
AJ Ribeiro, AK Denisin, RE Wilson, BL Pruitt |
Methods | 2015 |
5’RNA-seq identifies Fhl1 as a Modifier in Hypertrophic Cardiomyopathy
Danos Christodoulou, Hiroko Wakimoto, Kenji Onoue, Seda Eminaga, Joshua Gorham, Steven DePalma, Daniel Herman, Polakit Teekakirikul, David Conner, David McKean, Andrea Domenighetti, Anton Aboukhalil, Stephen Chang, Gyan Srivastava, Barbara McDonough, Philip De Jager, Ju Chen, Martha Bulyk, Jochen Muehlschlegel, Christine Seidman, Jonathan Seidman |
Journal of Clinical Investigation | 2014 |
Resident fibroblast lineages mediate pressure overload-induced cardiac fibrosis
Thomas Moore-Morris, Nuno Guimarães-Camboa, Indroneal Banerjee, Alexander Zambon, Tatiana Kisseleva, Aurelie Velayoudon, William B. Stallcup, Yusu Gu, Nancy Dalton, Martha Cedenilla, Rafael Gomez-Amaro, Bin Zhou, David A. Brenner, Kirk Peterson, Ju Chen, Sylvia Evans |
Journal of Clinical Investigation | 2014 |
Klotho and Phosphate Are Modulators of Pathologic Uremic Cardiac Remodeling
MC Hu, M Shi, HJ Cho, B Adams-Huet, J Paek, K Hill, J Shelton, AP Amaral, C Faul, M Taniguchi, M Wolf, M Brand, M Takahashi, M Kuro-o, JA Hill, OW Moe |
Journal of the American Society of Nephrology : JASN | 2014 |
-Myosin Heavy Chain Variant Val606Met Causes Very Mild Hypertrophic Cardiomyopathy in Mice, but Exacerbates HCM Phenotypes in Mice Carrying Other HCM Mutations
R Blankenburg, K Hackert, S Wurster, R Deenen, JG Seidman, CE Seidman, MJ Lohse, JP Schmitt |
Circulation research | 2014 |
(-)-Epicatechin improves mitochondrial-related protein levels and ameliorates oxidative stress in dystrophic δ-sarcoglycan null mouse striated muscle
I Ramirez-Sanchez, SD los Santos, S Gonzalez-Basurto, P Canto, P Mendoza-Lorenzo, C Palma-Flores, G Ceballos-Reyes, F Villarreal, A Zentella-Dehesa, R Coral-Vazquez |
FEBS Journal | 2014 |
Cardiac steatosis potentiates angiotensin II effects in the heart
DJ Glenn, MC Cardema, W Ni, Y Zhang, Y Yeghiazarians, D Grapov, O Fiehn, DG Gardner |
American journal of physiology. Heart and circulatory physiology | 2014 |
A role for membrane shape and information processing in cardiac physiology
R Knöll |
Pflügers Archiv - European Journal of Physiology | 2014 |
Hypertrophic cardiomyopathy in 2013: Current speculations and future perspectives
GK Efthimiadis, ED Pagourelias, T Gossios, T Zegkos |
World journal of cardiology | 2014 |
Hypertrophic cardiomyopathy: a heart in need of an energy bar?
S Vakrou, MR Abraham |
Frontiers in physiology | 2014 |
Granule cargo release from bone marrow-derived cells sustains cardiac hypertrophy
F Yang, A Dong, J Ahamed, M Sunkara, SS Smyth |
American journal of physiology. Heart and circulatory physiology | 2014 |
The Genetic Basis of Aortic Aneurysm
ME Lindsay, HC Dietz |
Cold Spring Harbor Perspectives in Medicine | 2014 |
Aldosterone Promotes Cardiac Endothelial Cell Proliferation In Vivo
B Gravez, A Tarjus, V Pelloux, A Ouvrard-Pascaud, C Delcayre, J Samuel, K Clement, N Farman, F Jaisser, S Messaoudi |
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease | 2014 |
Mammalian target of rapamycin is essential for cardiomyocyte survival and heart development in mice
P Zhang, T Shan, X Liang, C Deng, S Kuang |
Biochemical and Biophysical Research Communications | 2014 |
Myocardial fibrosis in patients with myotonic dystrophy type 1: a cardiovascular magnetic resonance study
H Petri, K Ahtarovski, N Vejlstrup, J Vissing, N Witting, L Køber, H Bundgaard |
Journal of Cardiovascular Magnetic Resonance | 2014 |
Familial hypertrophic cardiomyopathy: functional variance among individual cardiomyocytes as a trigger of FHC-phenotype development
B Brenner, B Seebohm, S Tripathi, J Montag, T Kraft |
Frontiers in physiology | 2014 |
Cardiovascular remodelling in coronary artery disease and heart failure
G Heusch, P Libby, B Gersh, D Yellon, M Böhm, G Lopaschuk, L Opie |
The Lancet | 2014 |
Adverse fibrosis in the aging heart depends on signaling between myeloid and mesenchymal cells; role of inflammatory fibroblasts
KA Cieslik, JA Trial, JR Crawford, GE Taffet, ML Entman |
Journal of Molecular and Cellular Cardiology | 2014 |
Identifying Gastric Cancer Related Genes Using the Shortest Path Algorithm and Protein-Protein Interaction Network
Y Jiang, Y Shu, Y Shi, LP Li, F Yuan, H Ren |
BioMed Research International | 2014 |
Fibrosis-Related Biomarkers and Risk of Total and Cause-Specific Mortality: The Cardiovascular Health Study
I Agarwal, NL Glazer, E Barasch, ML Biggs, L Djousse, AL Fitzpatrick, JS Gottdiener, JH Ix, JR Kizer, EB Rimm, DS Siscovick, RP Tracy, SJ Zieman, KJ Mukamal |
American Journal of Epidemiology | 2014 |
High Glucose Induces Sumoylation of Smad4 via SUMO2/3 in Mesangial Cells
X Zhou, C Gao, W Huang, M Yang, G Chen, L Jiang, F Gou, H Feng, N Ai, Y Xu |
BioMed Research International | 2014 |
High sensitivity of late gadolinium enhancement for predicting microscopic myocardial scarring in biopsied specimens in hypertrophic cardiomyopathy
T Konno, K Hayashi, N Fujino, Y Nagata, A Hodatsu, E Masuta, K Sakata, H Nakamura, M Kawashiri, M Yamagishi |
PloS one | 2014 |
Searching novel diagnostic markers and targets for therapy of CKD
P Kavvadas, JC Dussaule, C Chatziantoniou |
Kidney International Supplements | 2014 |
Decade in review—cardiomyopathies: Cardiomyopathy on the move
MH Yacoub |
Nature Reviews Cardiology | 2014 |
Inhibition of Periostin Expression Protects against the Development of Renal Inflammation and Fibrosis
M Mael-Ainin, A Abed, SJ Conway, JC Dussaule, C Chatziantoniou |
Journal of the American Society of Nephrology : JASN | 2014 |
Right Ventricular Epicardial Fibrosis in Mice With Sternal Segment Dislocation
HA Adissu, GA Medhanie, L Morikawa, JK White, S Newbigging, C McKerlie |
Veterinary pathology | 2014 |
A Role for Partial Endothelial-Mesenchymal Transitions in Angiogenesis?
KM Welch-Reardon, N Wu, CC Hughes |
Arteriosclerosis, thrombosis, and vascular biology | 2014 |
Hypertrophic cardiomyopathy: how do mutations lead to disease?
Marsiglia JD, Pereira AC |
Arquivos brasileiros de cardiologia | 2014 |
Stimulating myocardial regeneration with periostin Peptide in large mammals improves function post-myocardial infarction but increases myocardial fibrosis
D Ladage, E Yaniz-Galende, K Rapti, K Ishikawa, L Tilemann, S Shapiro, Y Takewa, J Muller-Ehmsen, M Schwarz, MJ Garcia, J Sanz, RJ Hajjar, Y Kawase |
PloS one | 2013 |
Allele-Specific Silencing of Mutant Myh6 Transcripts in Mice Suppresses Hypertrophic Cardiomyopathy
J Jiang, H Wakimoto, JG Seidman, CE Seidman |
Science | 2013 |
A clinical approach to inherited hypertrophy: the use of family history in diagnosis, risk assessment, and management
KE Dunn, C Caleshu, AL Cirino, CY Ho, EA Ashley |
Circulation. Cardiovascular genetics | 2013 |
Fibroblast growth factor receptor 1 signaling in adult cardiomyocytes increases contractility and results in a hypertrophic cardiomyopathy
SN Cilvik, JI Wang, KJ Lavine, K Uchida, A Castro, CM Gierasch, CJ Weinheimer, SL House, A Kovacs, CG Nichols, DM Ornitz |
PloS one | 2013 |
Stimulation of α1a adrenergic receptors induces cellular proliferation or antiproliferative hypertrophy dependent solely on agonist concentration
B Lei, DA Schwinn, DP Morris |
PloS one | 2013 |
Mineralocorticoid receptor antagonism attenuates experimental pulmonary hypertension
IR Preston, KD Sagliani, RR Warburton, NS Hill, BL Fanburg, IZ Jaffe |
American journal of physiology. Lung cellular and molecular physiology | 2013 |
Current perspectives in genetic cardiovascular disorders: from basic to clinical aspects
M Kawashiri, K Hayashi, T Konno, N Fujino, H Ino, M Yamagishi |
Heart and Vessels | 2013 |
Identification and comparative analyses of myocardial miRNAs involved in the fetal response to maternal obesity
A Maloyan, S Muralimanoharan, S Huffman, LA Cox, PW Nathanielsz, L Myatt, MJ Nijland |
2013 | |
p90 ribosomal S6 kinase 3 contributes to cardiac insufficiency in -tropomyosin Glu180Gly transgenic mice
CL Passariello, M Gayanilo, MD Kritzer, H Thakur, Z Cozacov, F Rusconi, D Wieczorek, M Sanders, J Li, MS Kapiloff |
American journal of physiology. Heart and circulatory physiology | 2013 |
The role of periostin in tissue remodeling across health and disease
SJ Conway, K Izuhara, Y Kudo, J Litvin, R Markwald, G Ouyang, JR Arron, CT Holweg, A Kudo |
Cellular and Molecular Life Sciences | 2013 |
A Novel Immunomodulator, FTY-720 Reverses Existing Cardiac Hypertrophy and Fibrosis From Pressure Overload by Targeting NFAT (Nuclear Factor of Activated T-cells) Signaling and Periostin
W Liu, M Zi, H Tsui, SK Chowdhury, L Zeef, QJ Meng, M Travis, S Prehar, A Berry, NA Hanley, L Neyses, RP Xiao, D Oceandy, Y Ke, RJ Solaro, EJ Cartwright, M Lei, X Wang |
Circulation. Heart failure | 2013 |
Severity of cardiomyopathy associated with adenine nucleotide translocator-1 deficiency correlates with mtDNA haplogroup
KA Strauss, L DuBiner, M Simon, M Zaragoza, PP Sengupta, P Li, N Narula, S Dreike, J Platt, V Procaccio, XR Ortiz-Gonzalez, EG Puffenberger, RI Kelley, DH Morton, J Narula, DC Wallace |
Proceedings of the National Academy of Sciences | 2013 |
Establishment of a novel murine model of ischemic cardiomyopathy with multiple diffuse coronary lesions
H Nakaoka, Y Nakagawa-Toyama, M Nishida, T Okada, R Kawase, T Yamashita, M Yuasa-Kawase, K Nakatani, D Masuda, T Ohama, T Sonobe, M Shirai, I Komuro, S Yamashita |
PloS one | 2013 |
Effects of Losartan on Left Ventricular Hypertrophy and Fibrosis in Patients With Nonobstructive Hypertrophic Cardiomyopathy
YJ Shimada, JJ Passeri, AL Baggish, C O'Callaghan, PA Lowry, G Yannekis, S Abbara, BB Ghoshhajra, RD Rothman, CY Ho, JL Januzzi, CE Seidman, MA Fifer |
JACC: Heart Failure | 2013 |
Smooth muscle LDL receptor-related protein-1 deletion induces aortic insufficiency and promotes vascular cardiomyopathy in mice
JE Basford, S Koch, A Anjak, VP Singh, EG Krause, N Robbins, NL Weintraub, DY Hui, J Rubinstein |
PloS one | 2013 |
Assessing the translatability of in vivo cardiotoxicity mechanisms to in vitro models using causal reasoning
AE Enayetallah, D Puppala, D Ziemek, JE Fischer, S Kantesaria, MT Pletcher |
BMC Pharmacology and Toxicology | 2013 |
Integrating the myocardial matrix into heart failure recognition and management
FG Spinale, MR Zile |
Circulation research | 2013 |
Aberrant differentiation of fibroblast progenitors contributes to fibrosis in the aged murine heart: role of elevated circulating insulin levels
KA Cieslik, JA Trial, S Carlson, GE Taffet, ML Entman |
The FASEB Journal | 2013 |
Alpha-tropomyosin mutations in inherited cardiomyopathies
C Redwood, P Robinson |
Journal of Muscle Research and Cell Motility | 2013 |
The Notch pathway controls fibrotic and regenerative repair in the adult heart
M Nemir, M Metrich, I Plaisance, M Lepore, S Cruchet, C Berthonneche, A Sarre, F Radtke, T Pedrazzini |
European Heart Journal | 2012 |
Genetic Considerations in Hypertrophic Cardiomyopathy
CY Ho |
Progress in Cardiovascular Diseases | 2012 |
Hypertrophic cardiomyopathy: Translating cellular cross talk into therapeutics
P Teekakirikul, RF Padera, JG Seidman, CE Seidman |
The Journal of Cell Biology | 2012 |
Cytokine mediated tissue fibrosis
LA Borthwick, TA Wynn, AJ Fisher |
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease | 2012 |
Matricellular Proteins in Cardiac Adaptation and Disease
NG Frangogiannis |
Physiological reviews | 2012 |
Coronary Artery Remodeling in a Model of Left Ventricular Pressure Overload Is Influenced by Platelets and Inflammatory Cells
F Yang, A Dong, P Mueller, J Caicedo, AM Sutton, J Odetunde, CJ Barrick, YM Klyachkin, A Abdel-Latif, SS Smyth |
PloS one | 2012 |
Epithelial-to-Mesenchymal and Endothelial-to-Mesenchymal Transition: From Cardiovascular Development to Disease
JC Kovacic, N Mercader, M Torres, M Boehm, V Fuster |
Circulation | 2012 |
Hypertrophic Cardiomyopathy: A Vicious Cycle Triggered by Sarcomere Mutations and Secondary Disease Hits
PJ Wijnker, V Sequeira, DW Kuster, J van der Velden |
Antioxidants & Redox Signaling | 2012 |
The Actin–MRTF–SRF Gene Regulatory Axis and Myofibroblast Differentiation
EM Small |
Journal of Cardiovascular Translational Research | 2012 |
Generation of mice with a conditional allele for the transforming growth factor beta3 gene
T Doetschman, T Georgieva, H Li, TD Reed, C Grisham, J Friel, MA Estabrook, C Gard, LP Sanford, M Azhar |
genesis | 2012 |
TGFβ-inducible early gene-1 (TIEG1) mutations in hypertrophic cardiomyopathy
JM Bos, M Subramaniam, JR Hawse, I Christiaans, NM Rajamannan, JJ Maleszewski, WD Edwards, AA Wilde, TC Spelsberg, MJ Ackerman |
Journal of Cellular Biochemistry | 2012 |
Intrapericardial Delivery of Gelfoam Enables the Targeted Delivery of Periostin Peptide after Myocardial Infarction by Inducing Fibrin Clot Formation
BD Polizzotti, S Arab, B Kühn |
PloS one | 2012 |
Identification of Periostin as a Critical Marker of Progression/Reversal of Hypertensive Nephropathy
D Guerrot, JC Dussaule, M Mael-Ainin, YC Xu-Dubois, E Rondeau, C Chatziantoniou, S Placier |
PloS one | 2012 |
The adult heart responds to increased workload with physiologic hypertrophy, cardiac stem cell activation, and new myocyte formation
CD Waring, C Vicinanza, A Papalamprou, AJ Smith, S Purushothaman, DF Goldspink, B Nadal-Ginard, D Torella, GM Ellison |
European Heart Journal | 2012 |
Thoracic aortic disease in two patients with juvenile polyposis syndrome and SMAD4 mutations
P Teekakirikul, DM Milewicz, DT Miller, RV Lacro, ES Regalado, AM Rosales, DP Ryan, TL Toler, AE Lin |
American journal of medical genetics. Part A | 2012 |
Roles of collagen and periostin expression by cranial neural crest cells during soft palate development
K Oka, MJ Honda, E Tsuruga, Y Hatakeyama, K Isokawa, Y Sawa |
The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society | 2012 |
Transforming growth factor beta signaling in adult cardiovascular diseases and repair
T Doetschman, JV Barnett, RB Runyan, TD Camenisch, RL Heimark, HL Granzier, SJ Conway, M Azhar |
Cell & Tissue Research | 2011 |
New paradigms in hypertrophic cardiomyopathy: Insights from genetics
CY Ho |
Progress in Pediatric Cardiology | 2011 |
Identifying Sarcomere Gene Mutations in Hypertrophic Cardiomyopathy: A Personal History
CE Seidman, JG Seidman, J Robbins, H Watkins |
Circulation research | 2011 |
Molecular mechanisms underlying cardiac antihypertrophic and antifibrotic effects of natriuretic peptides
C Calvieri, S Rubattu, M Volpe |
Journal of Molecular Medicine | 2011 |
Myosin binding protein C: implications for signal-transduction
R Knöll |
Journal of Muscle Research and Cell Motility | 2011 |
TGF-β signaling in fibrosis
A Biernacka, M Dobaczewski, NG Frangogiannis |
Growth Factors | 2011 |
Mechanisms of disease: hypertrophic cardiomyopathy
N Frey, M Luedde, HA Katus |
Nature Reviews Cardiology | 2011 |
Cellular mechanisms of cardiomyopathy
PA Harvey, LA Leinwand |
The Journal of Cell Biology | 2011 |
Genetics of sudden cardiac death syndromes
N Chopra, BC Knollmann |
Current Opinion in Cardiology | 2011 |
Periostin Is Induced in Glomerular Injury and Expressed de Novo in Interstitial Renal Fibrosis
K Sen, MT Lindenmeyer, A Gaspert, F Eichinger, MA Neusser, M Kretzler, S Segerer, CD Cohen |
The American Journal of Pathology | 2011 |
Chronic losartan administration reduces mortality and preserves cardiac but not skeletal muscle function in dystrophic mice
LT Bish, M Yarchoan, MM Sleeper, JA Gazzara, KJ Morine, P Acosta, ER Barton, HL Sweeney |
PloS one | 2011 |
Roles of TGF-β Signals in Endothelial-Mesenchymal Transition during Cardiac Fibrosis
Y Yoshimatsu, T Watabe |
International Journal of Inflammation | 2011 |
Barcoding bias in high-throughput multiplex sequencing of miRNA
S Alon, F Vigneault, S Eminaga, DC Christodoulou, JG Seidman, GM Church, E Eisenberg |
Genome research | 2011 |
Roles for CCN2 in normal physiological processes
F Hall-Glenn, KM Lyons |
Cellular and Molecular Life Sciences | 2011 |
Experimental mild renal insufficiency mediates early cardiac apoptosis, fibrosis, and diastolic dysfunction: a kidney-heart connection
FL Martin, PM McKie, A Cataliotti, SJ Sangaralingham, J Korinek, BK Huntley, EA Oehler, GE Harders, T Ichiki, S Mangiafico, KA Nath, MM Redfield, HH Chen, JC Burnett |
American Journal of Physiology - Regulatory, Integrative and Comparative Physiology | 2011 |
Phosphoinositide-3 kinase signaling in cardiac hypertrophy and heart failure.
Aoyagi T, Matsui T |
Current pharmaceutical design | 2011 |
Genetics and Clinical Destiny: Improving Care in Hypertrophic Cardiomyopathy
CY Ho |
Circulation | 2010 |
Pulmonary surfactant: an immunological perspective
ZC Chroneos, Z Sever-Chroneos, VL Shepherd |
Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology | 2009 |